Risk Factors for Contralateral Hematoma Progression after Unilateral Evacuation of Bilateral Chronic Subdural Hematomas.


Journal

World neurosurgery
ISSN: 1878-8769
Titre abrégé: World Neurosurg
Pays: United States
ID NLM: 101528275

Informations de publication

Date de publication:
Jun 2019
Historique:
received: 24 12 2018
revised: 24 02 2019
accepted: 25 02 2019
pubmed: 12 3 2019
medline: 17 1 2020
entrez: 12 3 2019
Statut: ppublish

Résumé

To find risk factors for contralateral hematoma progression (CHP) in bilateral chronic subdural hematomas after initial unilateral evacuation. We retrospectively analyzed 53 patients with bilateral chronic subdural hematomas who underwent unilateral surgical evacuation in our department. Risk factors for CHP were identified by univariate analysis, a P value <0.05 were entered into multivariate logistic regression model and a predictive receiver operating characteristic curve model. The progression rate was 32.08%, the average progression interval was 2.32 months. The progression rate of the homogeneous hypodense group was significantly higher than that of the other density group (P = 0.017). The limited type of contralateral hematoma had a significantly lower progression rate than that of the widespread type (P = 0.001). Both pre- and postoperative volume of contralateral hematoma were significantly more in the CHP group compared with the contralateral hematoma without progression group (P = 0.031 and P = 0.001, respectively). Of the 4 risk factors, only postoperative volume of contralateral hematoma was an independent risk factor in multivariate logistic regression model (P = 0.033; 95% confidence interval, 1.005-1.124). The cut-off values of contralateral hematoma volume before and after operation were 29.27 cm Contralateral hematoma volume after operation is an independent risk predictor for CHP after unilateral evacuation. An additional surgery on contralateral hematoma or medical treatment should be taken into consideration if the volume is >37.84 cm

Identifiants

pubmed: 30853519
pii: S1878-8750(19)30571-6
doi: 10.1016/j.wneu.2019.02.148
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e773-e778

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Jun Shen (J)

Department of Neurosurgery, Yijishan Hospital of Wannan Medical College, Wuhu, People's Republic of China. Electronic address: shenyuanziyan@163.com.

Xuefei Shao (X)

Department of Neurosurgery, Yijishan Hospital of Wannan Medical College, Wuhu, People's Republic of China.

YaLong Gao (Y)

Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, People's Republic of China.

Qifeng Li (Q)

Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, People's Republic of China.

Ruixiang Ge (R)

Department of Neurosurgery, Yijishan Hospital of Wannan Medical College, Wuhu, People's Republic of China.

Qifu Wang (Q)

Department of Neurosurgery, Yijishan Hospital of Wannan Medical College, Wuhu, People's Republic of China.

Wei Zhou (W)

Department of Neurosurgery, Yijishan Hospital of Wannan Medical College, Wuhu, People's Republic of China.

XiaoChun Jiang (X)

Department of Neurosurgery, Yijishan Hospital of Wannan Medical College, Wuhu, People's Republic of China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH